JPH11142392A - Method for evaluating toxicity with using cultured cell - Google Patents
Method for evaluating toxicity with using cultured cellInfo
- Publication number
- JPH11142392A JPH11142392A JP31048697A JP31048697A JPH11142392A JP H11142392 A JPH11142392 A JP H11142392A JP 31048697 A JP31048697 A JP 31048697A JP 31048697 A JP31048697 A JP 31048697A JP H11142392 A JPH11142392 A JP H11142392A
- Authority
- JP
- Japan
- Prior art keywords
- culture
- toxicity
- cultured
- cells
- collagen gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、動物培養細胞を包
埋し、培養したコラーゲンゲル培養物を用いた被検物質
の毒性評価法に関し、特に実験動物を用いずに、簡便に
化学薬品、化粧品、洗剤等の被検物質の毒性や安全性を
評価する方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for evaluating the toxicity of a test substance using a collagen gel culture in which animal culture cells are embedded and cultured. The present invention relates to a method for evaluating the toxicity and safety of test substances such as cosmetics and detergents.
【0002】[0002]
【従来の技術】従来、化学薬品、化粧品、洗剤等の被検
物質の毒性あるいは安全性試験は、ドレイズ試験法に代
表されるように、実験動物を用いて行われてきた。しか
し、その結果は、定量性や客観性の問題に加え、一種類
の被検物質に多数の動物が必要とされることから、経済
的観点または動物愛護の観点からも、動物実験に替わる
方法が求められている。2. Description of the Related Art Conventionally, toxicity or safety tests of test substances such as chemicals, cosmetics, detergents and the like have been carried out using laboratory animals, as represented by the Draize test method. However, the results show that, in addition to the problems of quantitativeness and objectivity, a large number of animals are required for one type of test substance, and this method is an alternative to animal experiments from an economic or animal welfare perspective. Is required.
【0003】動物実験代替法の一つとして、動物細胞を
使った方法、特に単層培養系を用いた方法が行われてい
る。しかし、生体内で該細胞は三次元的な配置、あるい
はコラーゲン等の結合組織に内封された状態で存在する
ため、必ずしも単層培養系での結果が、生体にそのまま
外挿できるとは限らない。また、単層培養系では生体内
での機能が失われる例も知られている。[0003] As an alternative to animal experiments, a method using animal cells, particularly a method using a monolayer culture system, has been used. However, since the cells are present in the living body in a three-dimensional arrangement or in a state enclosed in a connective tissue such as collagen, the results in a monolayer culture system cannot always be extrapolated to the living body as it is. Absent. It is also known that a monolayer culture system loses its function in a living body.
【0004】[0004]
【発明が解決しようとする課題】そこで、Bellらは、ヒ
ト繊維芽細胞をコラーゲンゲル内で培養したものを報告
している(米国特許第4,485,096 号明細書)。該培養物
は、真皮結合組織中の繊維芽細胞と同じ形態を有してお
り、該培養物を用いての毒性評価キットも市販されてい
る。該培養物を用いた毒性評価は、主にテトラゾリウム
塩(MTT)を用いた刺激終点での生存率を指標にする
方法が行われている。しかし、該方法では1つの培養物
から1点の生存率データしか得られず、1種の被検物質
の毒性を評価するには、濃度の異なるいくつかの点につ
いて、生存率を求めなければならないため、複数の培養
物が必要となる。したがって、多数の被検物質の毒性評
価を行う際は、経済的な負担となる問題があった。Thus, Bell et al. Reported that human fibroblasts were cultured in a collagen gel (US Pat. No. 4,485,096). The culture has the same morphology as fibroblasts in the dermal connective tissue, and a kit for evaluating toxicity using the culture is also commercially available. For toxicity evaluation using the culture, a method is mainly performed using the tetrazolium salt (MTT) and the survival rate at the end point of stimulation as an index. However, in this method, only one point of viability data is obtained from one culture, and in order to evaluate the toxicity of one test substance, the viability must be determined for several points at different concentrations. A plurality of cultures are required. Therefore, there is a problem that it is economically burdensome to evaluate the toxicity of many test substances.
【0005】その他、生体構造に類似した培養物を利用
した方法としては、皮膚刺激能の評価方法として、ヒト
皮膚ケラチン細胞または繊維芽細胞培養物、またはこれ
らの細胞の同時培養物を有効量の時間にわたり被検物質
で暴露し、テトラゾリウム塩からホルマザン色素への還
元により細胞生存率を測定することから、組成物の刺激
ポテンシャルを測定する方法(特開平6-180311号公報)
、あるいはコラーゲンゲル上に動物細胞を播種し、定
期的に培地交換を繰り返して、一定期間後、培地中に被
検物質を添加し、一定時間経過後に、動物細胞の機能を
測定する方法(特開平8-163996号公報) 等が公知であ
る。しかしながら、いずれも 1つの培養物から 1点の生
存率データしか得られず、Bellらの方法と同様な問題を
有している。[0005] In addition, as a method using a culture similar to the biological structure, a method for evaluating skin irritation is to use an effective amount of a human skin keratinocyte or fibroblast culture or a coculture of these cells. A method for measuring the stimulating potential of a composition by exposing to a test substance over a period of time and measuring cell viability by reduction of a tetrazolium salt to a formazan dye (Japanese Patent Application Laid-Open No. 6-180311)
Alternatively, a method of seeding animal cells on a collagen gel, periodically changing the medium, adding a test substance to the medium after a certain period of time, and measuring the function of the animal cells after a certain period of time (specifically) JP-A-8-163996) and the like are known. However, in each case, only one viability data can be obtained from one culture, which has the same problem as the method of Bell et al.
【0006】さらに、テトラゾリウム塩を利用しない毒
性評価方法として、動物培養細胞を被検物質で処理した
後、該細胞から遊離する乳酸脱水素酵素を測定する安全
性評価試験法が公知である(特開平4-148695号公報) 。
しかしながら、この測定法を用いても、毒性評価を行う
際は、上記と同様の問題を有していた。Further, as a toxicity evaluation method not using a tetrazolium salt, a safety evaluation test method is known in which cultured animal cells are treated with a test substance and lactate dehydrogenase released from the cells is measured. No. Hei 4-48695).
However, even when this measurement method is used, the toxicity evaluation has the same problem as described above.
【0007】[0007]
【課題を解決するための手段】本発明者らは、必要とす
る培養物の数量を少なくするために、被検物質の毒性検
出ならびに評価法について、種々鋭意、検討を行った結
果、被検物質の培養物から、培地中へ放出された乳酸脱
水素酵素量の経時的変化に基づく、毒性評価法を見出
し、本発明を完成するに至った。Means for Solving the Problems In order to reduce the number of required cultures, the present inventors have conducted intensive studies on methods for detecting and evaluating the toxicity of a test substance. The present inventors have found a toxicity evaluation method based on a change over time in the amount of lactate dehydrogenase released from a culture of a substance into a medium, and have completed the present invention.
【0008】すなわち、本発明は動物培養細胞を包埋
し、培養したコラーゲンゲル培養物を、有効時間にわた
り、被検物質で処理することにより、被検物質から培養
物中へ放出された細胞内酵素を経時的に測定することを
特徴とする毒性評価方法である。That is, the present invention provides a method for treating a collagen gel culture in which animal culture cells are embedded and cultured with a test substance for an effective period of time so that intracellular cells released from the test substance into the culture can be treated. This is a toxicity evaluation method characterized by measuring an enzyme over time.
【0009】[0009]
【発明の実施態様】本発明では、動物培養細胞を包埋培
養したコラーゲンゲル培養物を用いる。使用する動物培
養細胞としては、繊維芽細胞、筋細胞、脂肪細胞、血管
内皮細胞などがあり、間葉系の細胞、特に繊維芽細胞が
好適に使用される。また、株化した細胞であっても構わ
ない。動物種はヒト、ラット、マウス等の哺乳動物のも
のが使用できる。BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, a collagen gel culture in which animal culture cells are embedded and cultured is used. The animal cultured cells to be used include fibroblasts, muscle cells, fat cells, vascular endothelial cells, and the like. Mesenchymal cells, particularly fibroblasts, are preferably used. Moreover, the cells may be established cells. As animal species, mammals such as human, rat, mouse and the like can be used.
【0010】コラーゲンゲルはラット尾や牛腱から調製
できるが、市販のものが好適に使用できる。[0010] Collagen gel can be prepared from rat tail or bovine tendon, but commercially available one can be suitably used.
【0011】包埋培養とは、動物培養細胞とコラーゲン
溶液の混合液をゲル化させたものを培養することをい
う。動物培養細胞を包埋し、培養したコラーゲンゲル培
養物としては、例えば、ヒト培養繊維芽細胞を包埋し、
培養したコラーゲンゲル培養物があり、商標名、「マト
レックスTM」(製造・販売 東洋紡績)などがある。[0011] The embedding culture means culturing a gelled mixture of animal cultured cells and collagen solution. Animal culture cells are embedded, and as a cultured collagen gel culture, for example, human cultured fibroblasts are embedded,
There are cultured collagen gel cultures, such as trade name "Matrex TM" (manufactured and sold by Toyobo).
【0012】本発明に使用される被検物質としては、化
学薬品、化粧品、洗剤等が広く用いられる。As the test substance used in the present invention, chemicals, cosmetics, detergents and the like are widely used.
【0013】本発明では、これらの被検物質を水、生理
食塩水、培地等に溶解、あるいは固形の状態で、動物培
養細胞を包埋し、培養したコラーゲンゲル培養物に添加
し、有効時間にわたり処理する。In the present invention, these test substances are dissolved in water, physiological saline, a medium, or the like, or added in a solid state to a cultured collagen gel culture in which animal culture cells are embedded and cultured. Process over
【0014】ここで、有効時間とは、被検物質がコラー
ゲンゲル内の動物細胞に作用し、その被検物質が有する
毒性を発揮するのに充分な時間を指し、一般に、30分
〜24時間が望ましい。コラーゲンゲル培養物に被検物
質を暴露している間、細胞活動が維持できるよう培地に
て培養しながら行う。用いる培地としては、DMEM培
地、EMEM培地、PBSなどがあり、特に血清を含有
しないDMEM培地を使用することが好ましい。培養物
は本培地にて、例えば37℃で30分間〜24時間培養
を行う。Here, the term "effective time" refers to a time sufficient for the test substance to act on animal cells in the collagen gel and exhibit the toxicity of the test substance, and is generally 30 minutes to 24 hours. Is desirable. While exposing the test substance to the collagen gel culture, the culture is performed while culturing in a medium so that the cell activity can be maintained. Examples of the medium to be used include a DMEM medium, an EMEM medium, and PBS, and it is particularly preferable to use a DMEM medium containing no serum. The culture is cultured in this medium at, for example, 37 ° C. for 30 minutes to 24 hours.
【0015】特に、平板状のコラーゲンゲルについて
は、上面を被検物質に暴露させ、もう一方の面(下面)
を培地に接触させながら、培養を行うのが望ましい。こ
の場合、コラーゲンゲルの培養器材として、ミリセル
(ミリポア社製)、セルカルチャーインサート(ファル
コン社製)などがあり、例えば、トランスウェル(コー
スター社製)が好適に使用できる。In particular, for a plate-like collagen gel, the upper surface is exposed to a test substance, and the other surface (lower surface) is exposed.
It is desirable to perform the culture while contacting the medium with the medium. In this case, as a culture device for collagen gel, there are Millicell (Millipore), cell culture insert (Falcon), and the like. For example, Transwell (Coaster) can be suitably used.
【0016】被検物質によってコラーゲンゲル中の動物
細胞が死滅すると、該細胞死による細胞膜の溶解もしく
は被検物質の直接の作用による細胞膜の破壊が生じ、動
物細胞内に存在する種々の酵素が培地中に放出される。When animal cells in the collagen gel are killed by the test substance, the cell membrane is lysed by the cell death or the cell membrane is destroyed by the direct action of the test substance. Released during.
【0017】本発明では被検物質の処理中に経時的に上
記培地を採取し、その中に含まれる細胞内酵素量を測定
する。測定する細胞内酵素としては乳酸脱水素酵素、ア
ルカリホスファターゼ等があげられるが、特に乳酸脱水
素酵素は多くの細胞種について、細胞内に存在してお
り、簡単に酵素量が測定ができるため、便利である。In the present invention, the above medium is collected over time during the treatment of the test substance, and the amount of intracellular enzymes contained therein is measured. Intracellular enzymes to be measured include lactate dehydrogenase, alkaline phosphatase, and the like.In particular, lactate dehydrogenase is present in cells for many cell types, and the amount of enzyme can be easily measured. It is convenient.
【0018】乳酸脱水素酵素量の測定は、抗体による定
量法等もあるが、一般に該酵素活性を測定することが簡
便である。この場合、市販の乳酸脱水素酵素活性測定キ
ットが好適に使用される。The amount of lactate dehydrogenase can be measured by a quantitative method using an antibody, etc., but it is generally convenient to measure the enzyme activity. In this case, a commercially available kit for measuring lactate dehydrogenase activity is preferably used.
【0019】本発明における毒性の評価は、培地中に放
出された細胞内酵素量の経時的変化を観察することによ
り行う。例えば、ある一定量の酵素量が放出されるまで
に要する時間の長さを指標として、それが短時間である
ほど、毒性が強いと判断できる。また、濃度の異なる被
検物質間の毒性を比較する場合は、(濃度)×(時間)
積を指標とすることも可能である。The toxicity in the present invention is evaluated by observing the change over time in the amount of intracellular enzyme released into the medium. For example, using the length of time required to release a certain amount of enzyme as an index, it can be determined that the shorter the time, the stronger the toxicity. When comparing the toxicity between test substances with different concentrations, (concentration) x (time)
The product can be used as an index.
【0020】本発明方法を用いることにより、1つの濃
度点のみで毒性評価が可能となり、必要とする培養物数
量も従来より少なくすることができる。By using the method of the present invention, the toxicity can be evaluated at only one concentration point, and the required number of cultures can be reduced.
【0021】[0021]
【実施例】以下に、本発明を具体的に実施例でもって説
明する。実施例1 培養されたヒト繊維芽細胞を包埋し、培養したコラーゲ
ンゲル培養物は、商標名、マトレックス(製造・販売
東洋紡績)を用いた。該培養物は、培養されたヒト繊維
芽細胞とコラーゲンゲルとの混合物を一定期間培養し
て、製造したものである。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below with reference to specific embodiments. Example 1 A collagen gel culture in which cultured human fibroblasts are embedded and cultured is a trade name of Matrex (manufactured and sold).
Toyobo) was used. The culture is produced by culturing a mixture of cultured human fibroblasts and collagen gel for a certain period of time.
【0022】上記コラーゲンゲル培養物をアッセイプレ
ート(6穴プレート)に入れ、コラーゲンゲル培養物上
にアッセイ培地(製造・販売 東洋紡績)を5ml加
え、室温で30分間放置し、コラーゲンゲル培養物の洗
浄をアッセイ培地で行った。各ウェル内のアッセイ培地
を吸引して抜き取り、キット添付のアッセイ・リングに
シリコンを塗布し、コラーゲンゲル培養物上面に密着さ
せた。The above collagen gel culture is placed in an assay plate (6-well plate), 5 ml of an assay medium (manufactured and sold by Toyobo) is added to the collagen gel culture, and the mixture is left at room temperature for 30 minutes. Washing was performed with assay medium. The assay medium in each well was aspirated and withdrawn, silicone was applied to the assay ring provided with the kit, and brought into close contact with the top surface of the collagen gel culture.
【0023】アッセイプレートの各ウェルにアッセイ培
地(製造・販売 東洋紡績)を1.5ml加えた。37
℃インキュベーター内(湿度95%以上)にて、1時
間、上記ウェルを入れて、前培養を行った後、ウェル内
のアッセイ培地を吸引除去し、新たに各ウェルにアッセ
イ培地を1.5ml加えた。蒸留水で溶解した表1に示
される被検物質6種を80μl、培養物上面に付着させ
たアッセイ・リング中央部に添加した。このとき、何も
添加していないコラーゲンゲル培養物をネガティブコン
トロールとして用いた。37℃インキュベーター内(湿
度95%以上)にて、上記被検物質を暴露させたコラー
ゲンゲル培養物の培養を行い、0.5、1、2、4、
8、16時間経過後、ウェル内のアッセイ培地から、1
00μlの培地を採取し、次いで抜き取った分のアッセ
イ培地を新たに補充し、培養を継続した。1.5 ml of an assay medium (manufactured and sold by Toyobo) was added to each well of the assay plate. 37
After placing the wells in an incubator at 95 ° C (humidity: 95% or more) for 1 hour to perform pre-culture, the assay medium in the wells was removed by suction, and 1.5 ml of assay medium was newly added to each well. Was. 80 μl of the six test substances shown in Table 1 dissolved in distilled water were added to the center of the assay ring attached to the upper surface of the culture. At this time, a collagen gel culture without any addition was used as a negative control. In a 37 ° C. incubator (having a humidity of 95% or more), the collagen gel culture to which the test substance was exposed was cultured, and 0.5, 1, 2, 4,
After 8 and 16 hours, 1 well is removed from the assay medium in the well.
00 μl of the medium was collected, and then a fresh amount of the assay medium was replenished, and the culture was continued.
【0024】ポジティブコントロールサンプルは、0.
1%Tween20−アッセイ培地により、コラーゲン
ゲル培養物全組織から抽出されたサンプル液を用いた。
サンプリングしたアッセイ培地(S)、ネガティブコン
トロール(NC)、ポジティブコントロール(PC)、
ブランク(新鮮なアッセイ培地のみ、BL)について、
市販の乳酸脱水素酵素活性測定キット(和光純薬工業
(株))を用い、乳酸脱水素酵素活性を測定した。ポジ
ティブコントロールの活性量を100%として、各サン
プルの障害率を以下の計算式にて算出した。 障害率(T、%)={(S)−(BL)}×100/
(PC)。 ここで、T=20%となる暴露時間(ET20)と、用
いた被検物質の濃度(C)との積をCT20値とした。
用いた被検物質及び得られた結果を表1に示す。The positive control sample contains 0.
A sample solution extracted from all tissues of the collagen gel culture with 1% Tween 20-assay medium was used.
Sampled assay medium (S), negative control (NC), positive control (PC),
For blank (fresh assay medium only, BL)
Lactate dehydrogenase activity was measured using a commercially available lactate dehydrogenase activity measurement kit (Wako Pure Chemical Industries, Ltd.). Assuming that the activity amount of the positive control was 100%, the damage rate of each sample was calculated by the following formula. Failure rate (T,%) = {(S) − (BL)} × 100 /
(PC). Here, the product of the exposure time (ET20) at which T = 20% and the concentration (C) of the test substance used was defined as a CT20 value.
Table 1 shows the test substances used and the results obtained.
【0025】[0025]
【表1】 [Table 1]
【0026】表1から明らかなように、CT20値の低
いもの程、毒性が強くなる傾向が認められた。As is evident from Table 1, the lower the CT20 value, the stronger the toxicity.
【0027】[0027]
【発明の効果】本発明によると、1つの濃度点のみで毒
性評価が可能となり、必要とする培養物数量も従来より
少なくすることができる。よって、他種類の被検物質の
毒性をスクリーニングする場合、必要な経費が少なくす
み、また簡便に行うことができる。According to the present invention, the toxicity can be evaluated only at one concentration point, and the required number of cultures can be reduced. Therefore, when screening for the toxicity of another type of test substance, the required cost can be reduced and the screening can be performed easily.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 川村 良久 福井県敦賀市東洋町10番24号 東洋紡績株 式会社敦賀バイオ研究所内 ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Yoshihisa Kawamura 10-24 Toyocho, Tsuruga-shi, Fukui Toyobo Co., Ltd.
Claims (4)
ゲンゲル培養物を、有効時間にわたり、被検物質で処理
することにより、被検物質から培養物中へ放出された細
胞内酵素を経時的に測定することを特徴とする毒性評価
方法。1. A collagen gel culture in which animal culture cells are embedded and cultured, is treated with a test substance for an effective time, whereby the intracellular enzymes released from the test substance into the culture are treated with time. A method for evaluating toxicity, characterized in that the method is used to determine the toxicity.
請求項1記載の毒性評価方法。2. The method according to claim 1, wherein the cultured animal cells are human fibroblasts.
内酵素が、乳酸脱水素酵素である請求項1記載の毒性評
価方法。3. The toxicity evaluation method according to claim 1, wherein the intracellular enzyme released from the test substance into the culture is lactate dehydrogenase.
ゲンゲル培養物、培地および細胞内酵素測定試薬を含む
毒性評価試薬。4. A toxicity evaluation reagent comprising a collagen gel culture in which animal culture cells are embedded and cultured, a medium, and a reagent for measuring intracellular enzymes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31048697A JP3596658B2 (en) | 1997-11-12 | 1997-11-12 | Toxicity evaluation method using cultured cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31048697A JP3596658B2 (en) | 1997-11-12 | 1997-11-12 | Toxicity evaluation method using cultured cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH11142392A true JPH11142392A (en) | 1999-05-28 |
| JP3596658B2 JP3596658B2 (en) | 2004-12-02 |
Family
ID=18005824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP31048697A Expired - Lifetime JP3596658B2 (en) | 1997-11-12 | 1997-11-12 | Toxicity evaluation method using cultured cells |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3596658B2 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004523484A (en) * | 2000-11-17 | 2004-08-05 | ヴァージニア コモンウェルス ユニバーシティ インテレクチュアル プロパティー ファンデーション | Electroprocessed collagen |
| US6855504B2 (en) | 1999-08-04 | 2005-02-15 | Tosk, Inc. | In vivo high throughput toxicology screening method |
| US7615373B2 (en) | 1999-02-25 | 2009-11-10 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed collagen and tissue engineering |
| US7759082B2 (en) | 1999-02-25 | 2010-07-20 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed fibrin-based matrices and tissues |
-
1997
- 1997-11-12 JP JP31048697A patent/JP3596658B2/en not_active Expired - Lifetime
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7615373B2 (en) | 1999-02-25 | 2009-11-10 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed collagen and tissue engineering |
| US7759082B2 (en) | 1999-02-25 | 2010-07-20 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed fibrin-based matrices and tissues |
| US6855504B2 (en) | 1999-08-04 | 2005-02-15 | Tosk, Inc. | In vivo high throughput toxicology screening method |
| JP2004523484A (en) * | 2000-11-17 | 2004-08-05 | ヴァージニア コモンウェルス ユニバーシティ インテレクチュアル プロパティー ファンデーション | Electroprocessed collagen |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3596658B2 (en) | 2004-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kalweit et al. | A national validation project of alternative methods to the Draize rabbit eye test | |
| Cole et al. | Tartrate-resistant acid phosphatase in bone and cartilage following decalcification and cold-embedding in plastic. | |
| Medawar | The growth, growth energy, and ageing of the chicken’s heart | |
| Kosher et al. | Stimulation of in vitro somite chondrogenesis by procollagen and collagen | |
| Eisen | Human skin collagenase: localization and distribution in normal human skin | |
| US8222031B2 (en) | Three-dimensional skin model | |
| Goldstein et al. | Status of mitochondria in living human fibroblasts during growth and senescence in vitro: use of the laser dye rhodamine 123. | |
| Krahl | Metabolic Activities and Cleavage of Eggs of the Sea Urchin, Arbacia Punctulata a Review, 1932-1949 | |
| Lam | Biosynthesis of γ-aminobutyric acid by isolated axons of cone horizontal cells in the goldfish retina | |
| Henriksen et al. | Effect of diffusion distance on measurement of rat skeletal muscle glucose transport in vitro | |
| Swain et al. | Intracellular pH rises and astrocytes swell after portacaval anastomosis in rats | |
| JP2006509502A (en) | Gelatin-based material as a swab | |
| Spearman et al. | A comparison of the epidermis and pigment cells of the crocodile with those in two lizard species | |
| JPH06505636A (en) | Native skin tissue culture method | |
| Wyss-Huber et al. | In vitro synthesis and release of proteins by fat body and ovarian tissue of Leucophaea maderae during the sexual cycle | |
| Douglas et al. | Visualization of cellular aggregates cultured on a three dimensional collagen sponge matrix | |
| Ozaki | Localization and multiple forms of acetylcholinesterase in sea urchin embryos | |
| Kearn et al. | The chemical nature of host hatching factors in the monogenean skin parasites Entobdella soleae and Acanthocotyle lobianchi | |
| EP3523420B1 (en) | Compositions, devices and methods for in vitro testing of chemical microenvironment in cell cultures | |
| JP3596658B2 (en) | Toxicity evaluation method using cultured cells | |
| Persidsky et al. | Optimal conditions and comparative effectiveness of dimethyl sulphoxide and polyvinylpyrrolidone in preservation of bone marrow | |
| Rofe | Tissue culture and toxicology | |
| EP1650292A1 (en) | Method of storing and/or transporting in vitro cell cultures | |
| US20040023907A1 (en) | Infection model | |
| Van Haeringen et al. | Lactate dehydrogenase in tear fluid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040205 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040402 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040507 |
|
| A521 | Written amendment |
Effective date: 20040702 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Effective date: 20040819 Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Effective date: 20040901 Free format text: JAPANESE INTERMEDIATE CODE: A61 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 3 Free format text: PAYMENT UNTIL: 20070917 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080917 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080917 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090917 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 5 Free format text: PAYMENT UNTIL: 20090917 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100917 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 6 Free format text: PAYMENT UNTIL: 20100917 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110917 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 8 Free format text: PAYMENT UNTIL: 20120917 |